SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE
Clinical trials for SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for scleroderma patients with worsening lung disease?
Disease control CompletedThis study tested whether adding a strong immune-suppressing drug (cyclophosphamide) to standard steroid treatment (prednisone) could help stabilize or improve lung function in people with scleroderma-related lung scarring. Forty adults with worsening lung function took part. The…
Matched conditions: SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 22, 2026 12:06 UTC
-
New MRI method could spot lung damage without radiation
Diagnosis CompletedThis study tested whether MRI can detect and monitor interstitial lung disease (lung scarring) in people with scleroderma. Twenty-five adults with scleroderma underwent both MRI and CT scans. A subset also breathed in a special xenon gas to see how well their lungs exchange oxyge…
Matched conditions: SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE
Sponsor: University of Kansas Medical Center • Aim: Diagnosis
Last updated Jun 24, 2026 05:16 UTC